Dr. Heriberto Abraham Valencia-Gonzalez | Molecular | Best Researcher Award
Dr. Heriberto Abraham Valencia-Gonzalez | Instituto Nacional de Cancerologia | Mexico
Dr. Heriberto Abraham Valencia González is a passionate biomedical researcher specializing in cancer biology, with expertise in molecular and cellular biology techniques. Currently a Postdoctoral Associate Researcher at the Instituto Nacional de Cancerología México (INCan), he is dedicated to investigating the molecular mechanisms of cancer stem cells and their response to treatment. With a strong background in biochemical sciences and quality management, he has contributed to groundbreaking research on cervical cancer and DNA damage response. As a mentor and educator, he has guided numerous students in scientific research, fostering innovation and knowledge dissemination in oncology.
Professional Profile:
Suitability for Best Researcher Award
Dr. Heriberto Abraham Valencia González is an outstanding candidate for the Best Researcher Award due to his significant contributions to the field of cancer biology, particularly in the study of cancer stem cells and their response to treatment. His expertise in molecular and cellular biology has led to groundbreaking research on cervical cancer, with a focus on DNA damage response and tumor heterogeneity.
Education & Experience 🎓💼
Education:
- PhD in Biochemical Sciences – INCan/FQ-UNAM (2019) 🎓
- MSc. in Biochemical Sciences – INCan/FQ-UNAM (2012) 🧪
- Biologist Pharmaceutical Chemist – FESZ-UNAM (2009) 🔬
Experience:
- Postdoctoral Associate Researcher – Instituto Nacional de Cancerología, México (2019–Present) 🏥🔬
- Postgraduate Student – Instituto Nacional de Cancerología, México (2012–2019) 🧬
- Analytical Chemist – Compañía Internacional de Comercio S.A. de C.V. (2009) ⚗️
- Research Internship – IMSS, Epidemiology Department (2008) 🏥
- Researcher – UNAM, Pharmaceutical Lab (2007) 💊
Professional Development 🚀📚
Dr. Valencia González actively engages in scientific training, quality management, and biosafety. He has completed courses in Quality Management Systems, Genomic Medicine, Biosafety, and Scientific Innovation. His commitment to research extends to mentoring students, delivering lectures on cancer stem cells, and developing safety protocols in biomedical labs. He has contributed to international conferences, peer-reviewed publications, and a book chapter on cancer biology. His dedication to the advancement of oncology research and scientific education makes him a key figure in the field of molecular cancer research.
Research Focus 🧬🔍
Dr. Valencia González specializes in cancer biology, particularly in cancer stem cells and their role in tumor development and therapy resistance. His research explores the DNA damage response (DDR) pathways, molecular oncology, and novel antineoplastic treatments. His studies focus on cervical cancer, investigating epigenetic modifications, gene expression, and stemness markers. With expertise in cell culture, molecular biology, and animal models, his work aims to enhance personalized cancer treatments and develop targeted therapies. His research contributes to understanding tumor heterogeneity and improving radiotherapy and chemotherapy strategies.
Awards & Honors 🏆🎖️
- CONACYT National Researcher Candidate (2021–2024) 🏅
- Invited Speaker – Cancer Stem Cells Course, UNAM (2013, 2015) 🎤
- Thesis Advisor & Director – Supervised multiple undergraduate & graduate students 📚
- Multiple Research Publications in high-impact journals 📖
- Presented Research at International Conferences 🌎
Publication Top notes:
1️⃣ Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines (🔗 1 Citation)
2️⃣ Quantitative Proteomic Analysis of Cervical Cancer Tissues Identifies Proteins Associated With Cancer Progression (🔗 8 Citations)
3️⃣ Cancer stem cells from tumor cell lines activate the DNA damage response pathway after ionizing radiation more efficiently than noncancer stem cells (🔗 9 Citations)
4️⃣ Molecular iodine inhibits the expression of stemness markers on cancer stem-like cells of established cell lines derived from cervical cancer(🔗 18 Citations)
5️⃣ Inhibition of RAD51 by siRNA and resveratrol sensitizes cancer stem cells derived from hela cell cultures to apoptosis (🔗 32 Citations)